GBM also displayed statistically lower HAR1A and MIAT expression as compared with oligodendroglioma (P =0.002 and P =0.008), oligoastrocytoma (P =0.016 and P =0.044), and astrocytoma (P =0.009 and P =0.054). This evidence concerns the gene MIAT and astrocytoma (excluding glioblastoma).